The Patent Finder

Theragene Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Theragene Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to Theragene Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,636,998Method for enhanced uptake of viral vectors in the myocardium
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,221,738Method for enhanced uptake of viral vectors in the myocardium
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,583,662Methods and compositions for consistent intracoronary administration of a biologic
Formerly held
In force
 · USPTO record
In forceUSPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited